• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Industrials·MRO.L
Share

Melrose Industries PLC Stocks

£ 449.8Last Updated 12.10.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

£ 7.33B

£ 449.8
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Melrose Industries PLC, founded in London in 2003, is a global enterprise with core operations spanning the aerospace, automotive, powder metallurgy, and various other industrial sectors. Its geographical reach extends across the United Kingdom, the wider European continent, North America, and other international markets. Within its Aerospace division, the company specializes in manufacturing airframe and engine components, alongside electrical interconnection systems, for both commercial aircraft and defense platforms. The Automotive segment is dedicated to the engineering, production, and integration of advanced driveline technologies, specifically including vital components for electric vehicles. Melrose's Powder Metallurgy segment supplies precision metal powder parts for industrial and automotive applications, in addition to producing metal powder for broader powder metallurgy processes and spearheading innovations in additive manufacturing. Furthermore, the Other Industrial segment designs and fabricates ergonomic products tailored for diverse work, educational, and healthcare environments. This segment also delivers metal hydride-based hydrogen storage solutions suitable for a wide array of industrial and commercial uses. The company previously operated under the name New Melrose Industries PLC before officially changing to Melrose Industries PLC in November 2015.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of MRO.L is 674 and suggests 49.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.10.2026 02:46

The headquarters of the world's most valuable oil company was hit by a missile strike

14.10.2026 01:32

Bank of America was fined $1.2 billion for violations related to money laundering

14.10.2026 01:00

Goldman Sachs announced the emergence of two competing AI ecosystems in the U.S. and China

14.10.2026 00:28

Truist is among the top bulls on Meta: it predicts its stock will rise another 35%

13.10.2026 23:00

BioNTech reported another setback in the development of cancer drugs. Its stock plummeted

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026